Back

The genomic landscape of Acute Respiratory Distress Syndrome: a meta-analysis by information content of genome-wide studies of the host response.

Millar, J. E.; Clohisey-Hendry, S.; McManus, M.; Zechner, M.; Wang, B.; Parkinson, N.; Jungnickel, M.; Mohamad Zaki, N.; Pairo-Castineira, E. E.; Rawlik, K.; Rogers, J.; Russell, C. D.; Bos, L. D.; Meyer, N. J.; Calfee, C.; McAuley, D. F.; Shankar-Hari, M.; Baillie, J. K.

2024-02-14 intensive care and critical care medicine
10.1101/2024.02.13.24301089 medRxiv
Show abstract

Acute respiratory distress syndrome (ARDS) is a clinically defined syndrome of acute hypoxaemic respiratory failure secondary to non-cardiogenic pulmonary oedema. It arises from a diverse set of triggers and encompasses marked biological heterogeneity, complicating efforts to develop effective therapies. An extensive body of recent work (including transcriptomics, proteomics, and genome-wide association studies) has sought to identify proteins/genes implicated in ARDS pathogenesis. These diverse studies have not been systematically collated and interpreted. To solve this, we performed a systematic review and computational integration of existing omics data implicating host response pathways in ARDS pathogenesis. We identified 40 unbiased studies reporting associations, correlations, and other links with genes and single nucleotide polymorphisms (SNPs), from 6,856 ARDS patients. We used meta-analysis by information content (MAIC) to integrate and evaluate these data, ranking over 7,000 genes and SNPs and weighting cumulative evidence for association. Functional enrichment of strongly-supported genes revealed cholesterol metabolism, endothelial dysfunction, innate immune activation and neutrophil degranulation as key processes. We identify 51 hub genes, most of which are potential therapeutic targets. To explore biological heterogeneity, we conducted a separate analysis of ARDS severity/outcomes, revealing distinct gene associations and tissue specificity. Our large-scale integration of existing omics data in ARDS enhances understanding of the genomic landscape by synthesising decades of data from diverse sources. The findings will help researchers refine hypotheses, select candidate genes for functional validation, and identify potential therapeutic targets and repurposing opportunities. Our study and the publicly available computational framework represent an open, evolving platform for interpretation of ARDS genomic data.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.1%
22.0%
2
eBioMedicine
130 papers in training set
Top 0.1%
12.1%
3
iScience
1063 papers in training set
Top 0.4%
9.9%
4
eLife
5422 papers in training set
Top 10%
7.0%
50% of probability mass above
5
Scientific Reports
3102 papers in training set
Top 29%
4.2%
6
European Respiratory Journal
54 papers in training set
Top 0.4%
4.2%
7
JCI Insight
241 papers in training set
Top 2%
3.5%
8
PLOS Computational Biology
1633 papers in training set
Top 10%
3.5%
9
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.3%
3.5%
10
Frontiers in Molecular Biosciences
100 papers in training set
Top 0.8%
2.5%
11
Physiological Genomics
15 papers in training set
Top 0.1%
2.0%
12
Critical Care
14 papers in training set
Top 0.2%
1.8%
13
Frontiers in Immunology
586 papers in training set
Top 5%
1.3%
14
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
13 papers in training set
Top 0.2%
1.3%
15
Bioinformatics
1061 papers in training set
Top 8%
1.3%
16
Disease Models & Mechanisms
119 papers in training set
Top 2%
1.2%
17
PLOS ONE
4510 papers in training set
Top 63%
0.9%
18
Science Translational Medicine
111 papers in training set
Top 5%
0.9%
19
BMC Medical Genomics
36 papers in training set
Top 1%
0.9%
20
Cell Reports
1338 papers in training set
Top 32%
0.8%
21
Genome Medicine
154 papers in training set
Top 8%
0.7%
22
Pediatric Research
18 papers in training set
Top 0.5%
0.6%
23
Cell Reports Medicine
140 papers in training set
Top 10%
0.6%
24
Life Science Alliance
263 papers in training set
Top 3%
0.6%